Biowaiver monographs for immediate release solid oral dosage forms: Lamivudine
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing lamivudine as the only active pharmaceutical ingredient were reviewed. The solubility and permeability data of lamivudine as...
Saved in:
Main Authors: | S. Strauch, E. Jantratid, J. B. Dressman, H. E. Junginger, S. Kopp, K. K. Midha, V. P. Shah, S. Stavchansky, D. M. Barends |
---|---|
其他作者: | Goethe-Universitat Frankfurt am Main |
格式: | Article |
出版: |
2018
|
主題: | |
在線閱讀: | https://repository.li.mahidol.ac.th/handle/123456789/12834 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Mahidol University |
相似書籍
-
Biowaiver monographs for immediate release solid oral dosage forms: Mefloquine hydrochloride
由: S. Strauch, et al.
出版: (2018) -
Biowaiver monographs for immediate release solid oral dosage forms: Cimetidine
由: E. Jantratid, et al.
出版: (2018) -
The biowaiver procedure: Its application to antituberculosis products in the WHO prequalification programme
由: Stefanie Strauch, et al.
出版: (2018) -
Feasibility of biowaiver extension to Biopharmaceutics Classification System Class III drug products: Cimetidine
由: Ekarat Jantratid, et al.
出版: (2018) -
Feasibility studies on biowaiver extension of In vivo bioequivalence of class III drugs based on the biopharmaceutics classification system
由: Ekarat Jantratid
出版: (2023)